Soleno Therapeutics (SLNO, $45.12) was a top loser yesterday, declining to $45.12 per share. Of the 912 stocks analyzed in the Biotechnology Industry, of them (6) exhibited an Uptrend while of them (3) were in a Downtrend. 325 similar cases when SLNO's price dropped within one day were found. In out of those 325 cases, SLNO's price went down during the subsequent month. Based on these historical data, the odds of a Downtrend continuation for SLNO are